Corbus Pharmaceuticals I...
12.08
0.63 (5.50%)
At close: Jan 15, 2025, 12:28 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
PE Ratio -0.59 -0.25 -1.66 -0.88 -5.05 -5.98 -10.99 -17.38 -5.84 -23.73 -128.51 -23.54
PS Ratio n/a n/a 85.93 24.81 9.65 69.03 146.00 181.86 79.78 n/a n/a n/a
PB Ratio -3.79 0.42 1.10 2.16 56.66 12.09 6.17 38.97 5.76 10.28 -43.41 -105.25
P/FCF Ratio -0.72 -0.37 -1.57 -0.98 -7.2 -10.28 -12.5 -24.96 -10.86 -24.85 -211.08 -27.13
P/OCF Ratio -0.72 -0.37 -1.57 -0.98 -7.63 -11.07 -12.82 -25.61 -11.13 -25.53 -211.08 -27.13
OCF/S Ratio n/a n/a -54.65 -25.32 -1.26 -6.24 -11.39 -7.1 -7.17 n/a n/a n/a
Debt / Equity Ratio -3.02 0.76 0.38 0.59 1.53 0.01 0.01 0.03 0.02 0.02 -0.36 n/a
Quick Ratio 0.74 4.76 5.89 2.88 1.17 2.45 7.98 1.96 3.50 8.85 0.47 1.97
Current Ratio 0.74 4.76 5.89 2.89 1.09 2.45 7.98 1.96 3.50 8.85 0.47 1.97
Asset Turnover n/a n/a 0.01 0.04 0.74 0.10 0.04 0.11 0.05 n/a n/a n/a
Interest Coverage -15.42 -18.68 -30.59 -119.42 -4.05K n/a -177.83 n/a -3.63K -110.2 -12.35 n/a
Return on Equity (ROE) 6.46 -1.69 -0.66 -2.46 -11.23 -2.02 -0.56 -2.24 -0.99 -0.43 0.34 4.47
Return on Assets (ROA) -1.58 -0.84 -0.42 -1.09 -1.41 -1.18 -0.48 -1.12 -0.69 -0.38 -1.97 -1.63
Return on Capital (ROIC) 12.45 -0.74 -0.62 -1.74 -5.41 -1.96 -0.55 -2.22 -0.96 -0.45 1.62 -3.07
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a -85.92% 97.50% 99.75% -908.11% -967.09% -707.6% -808.21% n/a n/a n/a
Net Profit Margin n/a n/a -5.17K% -2.83K% -191.33% -1.15K% -1.33K% -1.05K% -1.37K% n/a n/a n/a
Pretax Profit Margin n/a n/a -5.18K% -2.83K% -197.69% -1.15K% -1.33K% -1.05K% -1.37K% n/a n/a n/a
Operating Profit Margin n/a n/a -6.35K% -3.12K% -213.33% -1.18K% -1.33K% -1.05K% -1.37K% n/a n/a n/a
FCF Margin n/a n/a -5.47K% -2.54K% -134.09% -671.21% -1.17K% -728.48% -734.37% n/a n/a n/a
EBITDA Margin n/a n/a -6.23K% -3.09K% -211.28% -1.17K% -1.32K% -1.04K% -1.36K% n/a n/a n/a